Market Overview:
The global Lab-on-a-chip and Microarrays(BIOCHIP) market is expected to grow at a CAGR of 10.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for miniaturized and portable devices, rising prevalence of chronic diseases, and growing investments in life sciences research. The DNA microarrays segment is expected to account for the largest share of the global Lab-on-a-chip and Microarrays(BIOCHIP) market in 2018. This segment is driven by the increasing demand for genomics applications such as gene expression profiling, SNP detection, ChIP analysis, methylation studies, etc. The cell assays segment is projected to grow at the highest CAGR during the forecast period owing to its growing use in drug discovery and development processes.
 Industry Outlook.svg)
Product Definition:
A lab-on-a-chip is a device that integrates one or more laboratory functions onto a single chip. Microarrays are arrays of microscopic spots on a glass slide, plastic cartridge, or other surface. Each spot contains one DNA molecule from an organism or tissue culture.
DNA Microarrays:
DNA microarrays are small pieces of DNA that are bound to a substrate or glass surface by an array of antibodies. The binding of the DNA to the antibody provides information about the presence, type and quantity of analytes in solution. It is one kind of genetic test or probe used for detecting and identifying specific genes, which can be used as diagnostic tools in medical diagnosis and research applications.
Microfluidics:
Microfluidics is the study of fluid motion at the molecular scale. It includes a wide range of techniques that are used to examine and analyze fluids with sub-micron resolution. Microfluidics has emerged as an important tool in biotechnology, chemical analysis, pharmaceuticals industries and environmental science among others.
Application Insights:
Genomics was the dominant application segment in the global lab-on-a-chip and biochips market. Genomic applications include DNA sequencing, gene expression analysis, and genome mapping. The advent of miniaturized genetic analyzers has revolutionized clinical research by enabling rapid screening of large numbers of patients for rare diseases with high accuracy. This has led to an increased demand for lab on a chip technology in genomic applications.
Proteomics is anticipated to witness significant growth over the forecast period owing to its rising adoption in various fields including drug discovery, disease diagnosis, nutritional diagnostics, food testing etcetera (others). Proteomics involves identification and characterization of proteins using several techniques such as mass spectroscopy (MS), gel extraction methods (tryptic digestion), western blotting etcetera (protein purification).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of major players, increased funding for R&D, and high adoption of advanced technologies. The U.S.-based companies are engaged in extensive research activities to develop novel products with better performance characteristics at a lower cost as compared to their counterparts overseas.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to increasing focus on biotechnology and life science sectors by various governments across countries such as China, India, Singapore & Japan etc., which has led bioinformatics companies active in this region gain significant traction over last few years (2010-2017).
Growth Factors:
- Increasing demand for personalized medicine
- Rising prevalence of chronic diseases
- Technological advancements in lab-on-a-chip and microarrays technology
- Growing number of public and private sector funding initiatives for research and development in lab-on-a-chip and microarrays technology
- Rising demand from emerging markets
Scope Of The Report
Report Attributes
Report Details
Report Title
Lab-on-a-chip and Microarrays(BIOCHIP) Market Research Report
By Type
DNA Microarrays, Microfluidics
By Application
Genomics, Proteomics, Cell Assays, Clinical Diagnostics, Drug Discovery, Others
By Companies
Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Beckman Coulter, Cepheid, Fluidigm, GE Healthcare, Roche Holding, Illumina, Biomerieux, Thermo Fisher Scientific, PerkinElmer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
240
Number of Tables & Figures
168
Customization Available
Yes, the report can be customized as per your need.
Global Lab-on-a-chip and Microarrays(BIOCHIP) Market Report Segments:
The global Lab-on-a-chip and Microarrays(BIOCHIP) market is segmented on the basis of:
Types
DNA Microarrays, Microfluidics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Genomics, Proteomics, Cell Assays, Clinical Diagnostics, Drug Discovery, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Agilent Technologies
- Bio-Rad Laboratories
- Beckman Coulter
- Cepheid
- Fluidigm
- GE Healthcare
- Roche Holding
- Illumina
- Biomerieux
- Thermo Fisher Scientific
- PerkinElmer
 Market Overview.svg)
Highlights of The Lab-on-a-chip and Microarrays(BIOCHIP) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA Microarrays
- Microfluidics
- By Application:
- Genomics
- Proteomics
- Cell Assays
- Clinical Diagnostics
- Drug Discovery
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lab-on-a-chip and Microarrays(BIOCHIP) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lab-on-a-chip is a technology that allows scientists to create miniature laboratory systems on a single chip. Microarrays are arrays of small, individual cells or pieces of DNA that can be used in scientific research.
Some of the major players in the lab-on-a-chip and microarrays(biochip) market are Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Beckman Coulter, Cepheid, Fluidigm, GE Healthcare, Roche Holding, Illumina, Biomerieux, Thermo Fisher Scientific, PerkinElmer.
The lab-on-a-chip and microarrays(biochip) market is expected to register a CAGR of 10.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Lab-on-a-chip and Microarrays(BIOCHIP) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Lab-on-a-chip and Microarrays(BIOCHIP) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Lab-on-a-chip and Microarrays(BIOCHIP) Market - Supply Chain
4.5. Global Lab-on-a-chip and Microarrays(BIOCHIP) Market Forecast
4.5.1. Lab-on-a-chip and Microarrays(BIOCHIP) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Lab-on-a-chip and Microarrays(BIOCHIP) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Lab-on-a-chip and Microarrays(BIOCHIP) Market Absolute $ Opportunity
5. Global Lab-on-a-chip and Microarrays(BIOCHIP) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Type
5.3.1. DNA Microarrays
5.3.2. Microfluidics
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Lab-on-a-chip and Microarrays(BIOCHIP) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Application
6.3.1. Genomics
6.3.2. Proteomics
6.3.3. Cell Assays
6.3.4. Clinical Diagnostics
6.3.5. Drug Discovery
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Lab-on-a-chip and Microarrays(BIOCHIP) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Lab-on-a-chip and Microarrays(BIOCHIP) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Lab-on-a-chip and Microarrays(BIOCHIP) Demand Share Forecast, 2019-2026
9. North America Lab-on-a-chip and Microarrays(BIOCHIP) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Application
9.4.1. Genomics
9.4.2. Proteomics
9.4.3. Cell Assays
9.4.4. Clinical Diagnostics
9.4.5. Drug Discovery
9.4.6. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Type
9.7.1. DNA Microarrays
9.7.2. Microfluidics
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Lab-on-a-chip and Microarrays(BIOCHIP) Demand Share Forecast, 2019-2026
10. Latin America Lab-on-a-chip and Microarrays(BIOCHIP) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Application
10.4.1. Genomics
10.4.2. Proteomics
10.4.3. Cell Assays
10.4.4. Clinical Diagnostics
10.4.5. Drug Discovery
10.4.6. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Type
10.7.1. DNA Microarrays
10.7.2. Microfluidics
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Lab-on-a-chip and Microarrays(BIOCHIP) Demand Share Forecast, 2019-2026
11. Europe Lab-on-a-chip and Microarrays(BIOCHIP) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Application
11.4.1. Genomics
11.4.2. Proteomics
11.4.3. Cell Assays
11.4.4. Clinical Diagnostics
11.4.5. Drug Discovery
11.4.6. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Type
11.7.1. DNA Microarrays
11.7.2. Microfluidics
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Lab-on-a-chip and Microarrays(BIOCHIP) Demand Share, 2019-2026
12. Asia Pacific Lab-on-a-chip and Microarrays(BIOCHIP) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Application
12.4.1. Genomics
12.4.2. Proteomics
12.4.3. Cell Assays
12.4.4. Clinical Diagnostics
12.4.5. Drug Discovery
12.4.6. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Type
12.7.1. DNA Microarrays
12.7.2. Microfluidics
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Lab-on-a-chip and Microarrays(BIOCHIP) Demand Share, 2019-2026
13. Middle East & Africa Lab-on-a-chip and Microarrays(BIOCHIP) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Application
13.4.1. Genomics
13.4.2. Proteomics
13.4.3. Cell Assays
13.4.4. Clinical Diagnostics
13.4.5. Drug Discovery
13.4.6. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Lab-on-a-chip and Microarrays(BIOCHIP) Market Size and Volume Forecast by Type
13.7.1. DNA Microarrays
13.7.2. Microfluidics
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Lab-on-a-chip and Microarrays(BIOCHIP) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Lab-on-a-chip and Microarrays(BIOCHIP) Market: Market Share Analysis
14.2. Lab-on-a-chip and Microarrays(BIOCHIP) Distributors and Customers
14.3. Lab-on-a-chip and Microarrays(BIOCHIP) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Agilent Technologies
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Bio-Rad Laboratories
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Beckman Coulter
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cepheid
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Fluidigm
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. GE Healthcare
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Roche Holding
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Illumina
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Biomerieux
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Thermo Fisher Scientific
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. PerkinElmer
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
